NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Distribution · USD

111, Inc. (YI) Stock Analysis

111, Inc. (YI) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

YI

$3.15

+$0.02 (+0.64%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare YI with… →

YI Key Statistics

As of Oct 21, 2026
Trading
Open
$3.15
Previous Close
$3.13
Day's Range
3.15–3.22
52-Week Range
2.48–11.17
Volume
6.44K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.67
Valuation
Market Cap
$27.71M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
22.50
Financials (FY)
Revenue (FY)
$12.56B−12.81%
Net Income (FY)
−$66.39M
Profit marginThe share of revenue left as profit after all costs and taxes.
−1.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
5.20M
1-Year Return
−30.62%
Dividend and dates
Avg Volume
11.33K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, YI closed at $3.15, −30.62% over 1 year.

111, Inc. (YI) has a market capitalization of $27.71M.

In fiscal 2025, YI reported revenue of $12.56B.

YI Stock Return by Calendar Year

111, Inc. (YI) return since Sep 2018: what $10,000 became

1 year
$10,000 $6,938
−30.62%
5 years
$10,000 $5,507
−44.93%
Since Sep 2018
$10,000 $2,283
−77.17%

If you had invested $10,000 in 111, Inc. (YI) at the close on September 12, 2018, the earliest close on record here, it would have been worth $2,283 at the close on October 21, 2026: −77.17% in total, −16.66% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+23.05%
2025+312.90%
2024−60.00%
2023−48.68%
2022−13.71%
2021−49.64%
2020+3.27%
2019+9.61%
2018 (partial year)−55.51%

As of October 21, 2026.

YI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$12.56B−$66.39M−0.5%
2024$14.40B−$64.74M−0.4%
2023$14.95B−$392.69M−2.6%
2022$13.52B−$416.88M−3.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$12.56B$723.41M−$2.38M−$66.39M−0.5%
2024$14.40B$829.23M$2.11M−$64.74M−0.4%
2023$14.95B$848.98M−$350.10M−$392.69M−2.6%
2022$13.52B$839.98M−$371.00M−$416.88M−3.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

YI Valuation vs Medical Distribution Median

Median of 11 stocks
MetricYIMedical Distribution medianvs median
P/S ratio0.000.380.0x the median
Profit margin−1.00%−4.73%3.7 pts above

Medians across 11 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

111, Inc. (YI) carries a market capitalisation of $27.71M. It is classified in the Medical Distribution industry, within the Healthcare sector. Headcount on file is 1,063.

Over the past 52 weeks the price has ranged from $2.48 to $11.17. The most recent close on file for YI is $3.15, dated October 21, 2026. That is +$0.02 (+0.64%) against the previous close. The latest close sits 27.02% above that 52-week low.

Financial Health

In fiscal 2025, 111, Inc. reported revenue of $12.56B. Against the prior fiscal year total of $14.40B, that is a change of −12.81%. The same year closed with a net loss of $66.39M. Profit margin runs at −1%. That is 3.7 percentage points above the Medical Distribution median of −4.73%.

Across the 4 fiscal years on file, revenue moves from $13.52B in 2022 to $12.56B in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 22.5.

Beta against the wider market is reported at 0.67. Annualized volatility over the trailing 8 years is 373.2%. Over the trailing twelve months the total return is −30.62%. Measured over 5 years, that is −11.25% a year compounded.

Growth & Income

The record shows no dividend for YI.

Across the complete calendar years on file, 2025 returned +312.90% and 2024 returned −60.00%. Of the 7 complete calendar years on file, 3 finished higher. 2026 is still running; the total return is +23.05% year to date.

Peer Comparison

111, Inc. (YI) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
111, Inc. YI $27.71M —
McKesson Corporation MCK $118.40B 27.2
Cencora, Inc. COR $64.96B 25.3
Cardinal Health, Inc. CAH $58.83B 35.1

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$118.40B

 COR

Cencora, Inc.

$64.96B

 CAH

Cardinal Health, Inc.

$58.83B

 HSIC

Henry Schein, Inc.

$9.47B

 AHG

Akso Health Group

$1.09B

 FOCL

EDAP TMS S.A.

$206.34M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About 111, Inc.

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Visit website →